| Rose F.R., Cyster L.A., Grant D.M., Scotchford C.A., Howdle S.M.,
Shakesheff K.M.
In vitro assessment of cell penetration into porous
hydroxyapatite scaffolds with a central aligned channel Biomaterials
2004; 25 (24): 5507-5514 [PUBMED] |
| |
| Hou Q.P., De Bank P.A., Shakesheff K.M. Injectable scaffolds for
tissue regeneration J. Mater. Chem. 2004;
14 (13): 1915-1923 |
| |
| Teare K.A., Pearson R.G., Shakesheff K.M., Raisman G., Haycock J.W.
Alpha-MSH inhibits inflammatory signalling in olfactory ensheathing
cells. Neuroreport 2004; 15(3):493-498 [PUBMED] |
| |
| Woods H.M., Silva M.M.C.G., Nouvel C., Shakesheff K.M., Howdle S.M.
Materials processing in supercritical carbon dioxide: surfactants,
polymers and biomaterials J. Mater. Chem. 2004;
14 (11): 1663-1678 |
| |
| Hao J.Y., Whitaker M.J., Wong B., Serhatkulu G., Shakesheff K.M.,
Howdle S.M Plasticization
and spraying of poly (DL-lactic acid) using supercritical carbon dioxide:
Control of particle size J. Pharm. Sci. 2004;
93 (4): 1083-1090 [PUBMED] |
| |
| Rose F.R., Hou Q., Oreffo R.O. Delivery systems for bone growth
factors - the new players in skeletal regeneration J. Pharm. Pharmacol.
2004; 56(4): 415-27 [PUBMED] |
| |
| Yang X.B., Whitaker M.J., Sebald W., Clarke N., Howdle S.M., Shakesheff
K.M., Oreffo R.O. Human osteoprogenitor bone formation using encapsulated
bone morphogenetic protein 2 in porous polymer scaffolds. Tissue
Eng 2004; 10 (7-8): 1037-1045
[PUBMED]
|
| |
| Quirk, R.A., France, R.M., Shakesheff, K.M., Howdle, S.M.
Supercritical fluid technologies and tissue engineering scaffolds.
Curr. Opin. Solid St. M. 2004; 8 (3-4): 313-32.
|
